Federally Funded Research Can Power Progress Against Cancer

0

This post originally appeared on the AACR Cancer Research Catalyst Blog.

This week, the American Association for Cancer Research (AACR) released the results of a national survey on American voters’ opinions about cancer and cancer research funding in conjunction with its fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to prioritize the growth of the budgets of the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA).

The results of the national AACR survey, conducted on behalf of the organization by Hart Research Associates and Public Opinion Strategies, fall in line with the messages in the AACR Cancer Progress Report 2015. For example, the national AACR survey shows that more than five out of every six voters (85 percent) recognize what the report details—progress is being made against cancer. The survey results also show that the majority of the electorate (69 percent) has the same message for Congress that the AACR has been delivering, through its annual Cancer Progress Report, for the past five years—increasing funding for medical research should be a top national priority.

AACR, cancer research

In a news release, Margaret Foti, PhD, MD (hc), chief executive officer of the AACR said, “We have made spectacular progress against cancer, which has saved the lives of millions of individuals in the United States and around the world. However, without increased federal funding for cancer research, we will not be able to realize the promise of recent discoveries and technological advances. Our national survey shows that this issue is a priority for most American voters, and the AACR is committed to advocating for increased federal funding for the lifesaving research that brings hope to cancer patients everywhere.”

SnapA_01_PR_CPR15_5YrSurvivalSnapA_02_PR_CPR15_FDAapp

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber clinicians have been involved in the development of several new agents approved recently for B-cell acu… https://t.co/Oo3SiY79EN
Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.